Loading…
Sino Biopharmaceutical Ltd, through its subsidiary invoX Pharma Ltd, acquired 100% of Softhale NV for US$110 million plus additional milestone payments. Softhale is a Belgian company developing respiratory disease treatments and a Soft Mist Inhalation device.